Most GLP-1 telehealth programs look identical on the surface. They are not.
Price gaps run from $99 to over $400 a month for the same active ingredient. Pharmacy oversight ranges from named, inspected 503A facilities to vague “licensed compounding partner” language that tells you nothing. Some programs pile on coaching you may not want. Others are bare-bones scripts with no follow-up. After testing five of the most widely used options, here is what actually separates them.
1. Mochi Health: Best for Medical Depth
Mochi puts board-certified obesity-medicine physicians on every case. That is a real credential, not a general practitioner clicking through a queue. Compounded semaglutide starts at $99 a month, tirzepatide at $199, and the monitoring is heavier than most cash-pay programs at that price. You get dose titration guidance, follow-up check-ins, and clinicians who treat excess weight as a metabolic condition rather than a willpower problem.
The tradeoff: the extra clinical layer means a slightly slower intake process. If you want the cheapest script with the least friction, this is not your fastest path. If you want someone actually watching your progress, Mochi earns the top slot.
2. Ro Body: Best for Insurance Navigation
Ro is the program to consider if branded medication with insurance is your goal. The first month runs about $39, then $74 to $149 monthly, with medications billed separately. The reason Ro makes this list is its prior-authorization team. Getting a GLP-1 covered by insurance is genuinely difficult, and Ro employs staff who work that process on your behalf.
Cash-pay compounded options are cheaper upfront. But if your insurer will cover Wegovy or Zepbound, Ro’s $0 to $25 out-of-pocket scenarios are real numbers, not marketing. That math changes everything for patients with qualifying coverage.
3. FormBlends: Best for Purity-Focused Buyers or Broader Peptide Use
FormBlends sits in an interesting spot. It is a compounded GLP-1 telehealth service with physician oversight, dispensed through an FDA-registered 503A compounding pharmacy, and it does something most programs skip: it publishes per-product purity testing. Actual HPLC purity numbers, mass spectrometry identity confirmation, endotoxin and sterility results, named per vial. You can read the certificate, not just a company promise.
That matters to a specific kind of buyer. Someone with a chemistry or clinical background, or simply anyone who has read about quality variation in the compounding market, will find that documentation reassuring in a concrete way. Semaglutide runs around $299 and tirzepatide around $349, so this is not a budget option.
FormBlends also carries a broader peptide catalog covering recovery, longevity, and cognitive support under the same clinician model. Most GLP-1-only telehealth brands offer nothing outside weight-loss medications. If you want one provider for multiple peptide protocols, that catalog is a real differentiator.
Why does it sit below HealthRX here? Purely price and shipping reach. Ships to 47 states, not 50, and the entry price is higher. For the right buyer, those trade-offs are worth it. For pure GLP-1 value, HealthRX edges it out.
4. Henry Meds: Best for Fast, Simple Cash-Pay Access
Henry Meds is built for speed. Compounded GLP-1s at $179 to $249 for month one, shipping in 24 to 72 hours, no insurance required. The process is intentionally minimal. You complete an intake, a prescriber reviews it, medication ships.
The monitoring is lighter than Mochi or Ro. Henry Meds works well for people who have already done the research, know what they want, and do not need hand-holding. It works less well if you want detailed dosing support or ongoing clinical coaching. Pick accordingly.
5. HealthRX: Best Budget-Friendly Option with Verifiable Pharmacy Transparency
HealthRX does not try to be everything. It is a direct telehealth service aimed at one thing: affordable compounded GLP-1 access with a clear paper trail on where the medication comes from.
Compounded semaglutide starts at $99 a month. Tirzepatide starts at $149. Those are the lowest entry prices in this comparison by a meaningful margin. Overnight shipping is included and free across all 50 states, which is not standard in this category.
The physician review happens within roughly 24 hours of intake. Medication is dispensed by Manifest Pharmacy in Greer, South Carolina, a 503A compounding pharmacy operating under USP-797 standards with lot tracking from production to delivery. The service holds LegitScript certification (certificate number 50087439), which is an independently verifiable credential that a lot of telehealth sites skip.
One thing to be clear about: compounded medications are not FDA-approved products. HealthRX’s semaglutide and tirzepatide are compounded formulations, not equivalent to branded drugs from the original manufacturers. The trial data often cited in this space, roughly 15% body weight loss over 68 weeks for semaglutide (STEP 1) and around 21% over 72 weeks for tirzepatide (SURMOUNT-1), comes from studies on the branded molecules, not compounded versions.
So who is HealthRX for? Someone paying cash who wants the lowest monthly cost, confirmed 50-state coverage with fast delivery, and can point to a named, inspectable pharmacy rather than an anonymous lab. That combination is harder to find than it should be.
Quick Comparison
| Program | Starting Price | Pharmacy Type | Key Strength |
| Mochi Health | $99/mo (sema) | Compounded | Obesity-medicine clinicians |
| Ro Body | ~$39 first month | Branded + compounded | Insurance navigation |
| FormBlends | ~$299 (sema) | 503A, published CoAs | Purity testing, peptide catalog |
| Henry Meds | ~$179 first month | Compounded | Fast, low-friction intake |
| HealthRX | $99/mo (sema) | Manifest Pharmacy, 503A | Price + 50-state overnight shipping |
Frequently Asked Questions
Are compounded GLP-1s the same as Ozempic or Wegovy?
No. Compounded semaglutide and tirzepatide are not FDA-approved and are not manufactured by the original drug makers. They contain the same active ingredient but are produced by compounding pharmacies under different regulatory frameworks.
Why did the FDA send warning letters to telehealth companies in early 2026?
The FDA issued letters to more than 30 compounding-related telehealth and pharmacy operations over concerns about quality, labeling, and claims. The March 2026 Novo settlement also pushed several brands away from compounded formulations toward branded medications. It is worth asking any provider which pharmacy fills your prescription and whether that pharmacy is 503A or 503B registered.
What does LegitScript certification actually mean?
LegitScript reviews telehealth and pharmacy operations for compliance with applicable laws and standards. Certification is not a government endorsement, but it does mean the company passed an independent verification process. HealthRX holds certificate 50087439.
Will insurance cover any of these programs?
Insurance typically does not cover compounded GLP-1s. For branded medications like Wegovy or Zepbound, coverage depends on your plan and diagnosis. Ro and PlushCare actively support prior-authorization processes for branded prescriptions.
How do I choose between semaglutide and tirzepatide?
That is a clinical question for your prescribing physician, not a website. Tirzepatide trial data showed higher average weight loss, but individual response varies, side-effect profiles differ, and your medical history matters. Start with a provider who does a real intake review, not a checkbox form.
Sources
- SURMOUNT-1 trial results, published in the New England Journal of Medicine (2022), Jastreboff et al.
- STEP 1 trial results, published in the New England Journal of Medicine (2021), Wilding et al.
- FDA compounding oversight and 503A/503B framework, FDA.gov
- LegitScript certification database, LegitScript.com
- Novo Nordisk compounding settlement reporting, March 2026, Reuters and STAT News
- Lilly orforglipron pricing via LillyDirect, reported April 2026, CNBC
